Insider Trading & Ownership - Schneiderman Daniel H

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Schneiderman Daniel H

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award(A)
2024-04-05
9:45 pm
N/A
2034-02-28
Pasithea Therapeutics Corp.KTTASchneiderman Daniel H
Chief Financial Officer
15,927$015,927
(Direct)
View
2024-03-01
Option Award
2024-03-01
9:46 pm
N/A
2034-02-28
Pasithea Therapeutics Corp.KTTASchneiderman Daniel H
Chief Financial Officer
15,927$015,927
(Direct)
View
2022-10-11
Option Award
2022-10-12
8:15 pm
2023-10-11
2032-10-11
Pasithea Therapeutics Corp.KTTASchneiderman Daniel H
Chief Financial Officer
300,000$0300,000
(Direct)
View
2022-01-03
Option Award
2022-01-03
9:07 pm
N/A
2032-01-03
First Wave BioPharma Inc.FWBISchneiderman Daniel H
CHIEF FINANCIAL OFFICER
10,000$010,000
(Direct)
View
2021-06-30
Option Award
2021-07-02
5:09 pm
N/A
2031-06-30
AzurRx BioPharma Inc.AZRXSchneiderman Daniel H
CHIEF FINANCIAL OFFICER
285,006$0285,006
(Direct)
View
2021-06-30
Other
2021-07-02
5:09 pm
N/A
2030-07-15
AzurRx BioPharma Inc.AZRXSchneiderman Daniel H
CHIEF FINANCIAL OFFICER
285,006$0285,006
(Direct)
View
2020-07-16
Option Award
2020-07-20
9:51 pm
N/A
2030-07-15
AzurRx BioPharma Inc.AZRXSchneiderman Daniel H
CHIEF FINANCIAL OFFICER
285,006$0585,006
(Direct)
View
2020-07-16
Other
2020-07-20
9:51 pm
N/A
2030-01-02
AzurRx BioPharma Inc.AZRXSchneiderman Daniel H
CHIEF FINANCIAL OFFICER
35,006$0585,006
(Direct)
View
2020-01-02
Option Award
2020-01-09
4:10 pm
N/A
2030-01-02
AzurRx BioPharma Inc.AZRXSchneiderman Daniel H
CHIEF FINANCIAL OFFICER
335,006$0335,006
(Direct)
View

Ownership
2020-01-09
4:05 pm
N/A
N/A
AzurRx BioPharma Inc.AZRXSchneiderman Daniel H
CHIEF FINANCIAL OFFICER
0$01,000
(Direct)
View
(A) Indicate amendment filing.